Review of the Federal Bureau of Prisons' Pharmaceutical Drug Costs and Procurement
- NARA ID
- review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Source
- oig-doj
- Collection
- DOJ OIG — Federal Bureau of Prisons
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2020-02-20
- Slug
- doj-oig-review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Indexed
- 2026-04-27 05:04:10
More from DOJ OIG — Federal Bureau of Prisons
- Notification of Concerns Regarding Conditions at Federal Correctional Institution Terre Haute
- Audit of the Federal Bureau of Prisons Annual Financial Statements Fiscal Year 2018
- Audit of the Federal Bureau of Prisons’ Sole-Source Contract Actions
- Staff Perceptions of the Federal Bureau of Prisons' Management of the Coronavirus Disease 2019 Pandemic: A Follow-Up Survey of BOP Staff
- Remote Inspection of Federal Correctional Complex Butner
- Audit of the Federal Prison Industries, Inc. Annual Financial Statements Fiscal Year 2017
Browse all 158 documents in DOJ OIG — Federal Bureau of Prisons →
About the DOJ OIG — Federal Bureau of Prisons collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Federal Bureau of Prisons.